Madrigal Pharmaceuticals, Inc. MDGL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

54/100

2/7 Pass

SharesGrow Intrinsic Value

Madrigal Pharmaceuticals, Inc. (MDGL) has 20 known insider and institutional holders on record. The largest holder is BAY CITY CAPITAL LLC with 2,310,521 shares. Other notable holders include Kovner Bruce and Taub Rebecca.

Over the last 12 months, insiders have made 30 transactions in MDGL stock — 13 buys (valued at $20.93M) and 12 sells (valued at $4.63M). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

MDGL Insider Ownership

Top Holder

BAY CITY CAPITAL LLC

2,310,521 shares

Buys (12 mo)

$20.93M value

Sells (12 mo)

$4.63M value

12-Month Transaction Activity

Buy 43%

Sell 40%

Top Insider Holders

#	Name	Role	Shares Owned	Last Filed	Relative Size
1	Bay City Capital Llc	10 Percent Owner	2,310,521	2020-12-01	100%
2	Kovner Bruce	10 Percent Owner	837,021	2015-12-08	36%
3	Taub Rebecca	Director	452,213	2026-03-06	20%
4	Vukovic Vojo	SVP, Chief Medical Officer	132,300	2015-10-06	6%
5	Mcmahon Arthur	SVP, Human Resources	126,768	2015-03-04	5%
6	Whitaker Anne Clem	President and CEO	100,000	2015-03-04	4%
7	Ramachandra Sumant	President, R&d	75,000	2013-03-13	3%
8	Singh Amar	Sr. VP, Chief Business Officer	73,505	2013-03-07	3%
9	Ehrlich Keith S	VP, Fin. and Admin., CFO	66,985	2014-03-05	3%
10	Schor Chen	Former President and CEO	37,178	2016-07-22	2%
11	Schneebaum Marc R	Chief Financial Officer	32,000	2021-02-23	1%
12	Bernitz Steven B	SVP, Corporate Development	25,000	2013-12-20	1%
13	Reardon William S	Director	20,000	2015-07-06	1%
14	Wilson Robert N	Director	20,000	2015-07-06	1%
15	Kufe Donald W	Director	20,000	2015-07-06	1%
16	Sibold William John	President and CEO	18,743	2026-03-06	1%
17	Morenstein Scott D	Director	17,857	2016-01-05	1%
18	Rieder Wendy E	Former SVP, Gen. Counsel	17,730	2016-07-22	1%
19	Sukhija Remy	Chief Commercial Officer	15,001	2023-01-18	1%
20	Bahcall Safi R	President and CEO	15,000	2014-02-13	1%

Recent Transactions (last 12 months)

Date	Name	Role	Type	Shares	Price	Value
2026-03-06	Kelley Shannon T	General Counsel	Informative Sell	360	$431.94	$155.5K
2026-03-04	Kelley Shannon T	General Counsel	RSU Award	5,022	$434.80	$2.18M
2026-03-06	Huntsman Carole	Chief Commercial Officer	Informative Sell	419	$431.94	$180.98K
2026-03-04	Huntsman Carole	Chief Commercial Officer	RSU Award	4,986	$434.80	$2.17M
2026-03-04	Soergel David	Chief Medical Officer	RSU Award	5,467	$434.80	$2.38M
2026-03-06	Dier Mardi	EVP and CFO	Informative Sell	40	$437.65	$17.51K
2026-03-04	Dier Mardi	EVP and CFO	RSU Award	6,519	$434.80	$2.83M
2026-03-06	Sibold William John	President and CEO	Informative Sell	1,663	$431.94	$718.32K
2026-03-04	Sibold William John	President and CEO	RSU Award	18,743	$434.80	$8.15M
2026-03-06	Taub Rebecca	Director	Informative Sell	491	$431.94	$212.08K
2026-03-02	Dier Mardi	EVP and CFO	Informative Sell	1,183	$427.21	$505.39K
2026-02-23	Levy Richard S	Director	Option Exercise (Sell)	2,500	$7.36	$18.4K
2026-01-26	Huntsman Carole	Chief Commercial Officer	Informative Sell	570	$494.59	$281.92K
2026-01-26	Sibold William John	President and CEO	Informative Sell	1,577	$492.42	$776.55K
2026-01-26	Levy Richard S	Director	Option Exercise (Sell)	4,000	$16.46	$65.84K
2026-01-26	Taub Rebecca	Director	Informative Sell	647	$492.42	$318.6K
2026-01-15	Thakkar Rita	Chief Accounting Officer	RSU Award	1,826	$495.88	$905.48K
2026-01-12	Thakkar Rita	Officer	Unknown	-	-	-
2026-01-20	Kelley Shannon T	General Counsel	Informative Sell	429	$501.40	$215.1K
2026-01-20	Taub Rebecca	Director	Informative Sell	2,238	$490.77	$1.1M
2026-01-09	Taub Rebecca	Director	Informative Sell	271	$534.18	$144.76K
2026-01-09	Friedman Paul A	Director	Option Exercise (Sell)	24,520	$15.80	$387.42K
2025-06-20	Daly James M	Director	RSU Award	1,290	$285.73	$368.59K
2025-06-20	Levy Richard S	Director	RSU Award	1,290	$285.73	$368.59K
2025-06-20	Fouse Jacqualyn A	Director	RSU Award	366	$285.73	$104.58K